ONE-WAYDated event · through FY2025-H1
Joint development through AI Bio of antibody therapeutics and diagnostics for infectious diseases
An individual project conducted through AI Bio, a joint venture with ABCONTEK, to jointly develop candidate antibody therapeutics and diagnostics for infectious diseases including SFTS and COVID-19, and to advance the introduction of antibody gene sequences and generate licensing revenue.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2021-Q3 →Last written FY2025-H1
Directionhelps1 helps · 0 hurts · 0 flat